Rogco LP’s NeoGenomics NEO Stock Holding History

Rogco LP’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$223	Hold	30	–	–	﹤0.01%	204
2025 Q4	$353	Hold	30	–	–	﹤0.01%	204
2025 Q3	$232	Buy	+30	New	+$210	﹤0.01%	192

Other funds holding NEO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Rogco LP's NEO Position: Q1 2026 in Review

Rogco LP held its NeoGenomics (NEO) position steady in Q1 2026 at 30 shares worth $223. The position accounts for ﹤0.01% of the portfolio, ranked #204.

Rogco LP first reported a position in NEO in Q3 2025 and has held it in 3 quarters since. The position peaked at $353 in Q4 2025. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

Rogco LP held 30 shares of NeoGenomics worth $223 as of Q1 2026.
Rogco LP left its NeoGenomics share count unchanged in Q1 2026.
NeoGenomics made up ﹤0.01% of Rogco LP's portfolio in Q1 2026, its #204 holding.
Rogco LP first reported a position in NeoGenomics in Q3 2025 and has held it in 3 quarters since.
Rogco LP's NeoGenomics position peaked at $353 in Q4 2025.
253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on Rogco LP's 13F filing for Q1 2026, filed 5 May 2026.